Aronson Capital Partners (“ACP”) is pleased to announce the acquisition of the Preclinical Services Business of Advanced Bioscience Laboratories, Inc. (“ABL”) by BIOQUAL, Inc. ACP served as the exclusive financial advisor to BIOQUAL in this transaction.